Literature DB >> 3452021

Urine albumin creatinine ratio and clinical correlates in a diabetic population.

J Woolerton1, D R Jury, P J Dunn, J F Speed.   

Abstract

The urine albumin/creatinine ratio was measured in random urine samples in a range of diabetic subjects as a guide to urinary albumin excretion rate in diabetic patients. In 74 control subjects the 95th percentile for the albumin/creatinine ratio was 1.3. In 39 diabetic patients the random urine albumin/creatinine ratio correlated highly with the 24 hour urine albumin excretion (r = 0.9371, p less than 0.001). In 337 insulin treated diabetic subjects 55% of the female and 39% of the male values exceeded 1.3. In 98 noninsulin treated diabetic subjects 67% of female and 62% of male values exceeded 1.3. Selecting albumin/creatinine ratios between 2.5 to 26.8 corresponding to albumin excretion rates between 20 mg and 250 mg/day, 26.1% of the insulin treated group were in this microalbuminuric range, and 8.7% had overt albuminuria. Higher figures were seen in the noninsulin treated group. Within these two large diabetic groups significant associations (p less than 0.005) were seen with glycaemia, blood pressure, body mass index, retinopathy and duration of diabetes. We believe that measurement of albumin/creatinine ratios on random urine samples offers a simple and convenient way of monitoring albumin excretion in large numbers of diabetic patients.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3452021

Source DB:  PubMed          Journal:  N Z Med J        ISSN: 0028-8446


  4 in total

Review 1.  Microalbuminuria in diabetes mellitus.

Authors:  Sheldon W Tobe; Philip Alan McFarlane; David Malcolm Naimark
Journal:  CMAJ       Date:  2002-09-03       Impact factor: 8.262

2.  Cardiovascular disease in Navajo Indians with type 2 diabetes.

Authors:  W Hoy; A Light; D Megill
Journal:  Public Health Rep       Date:  1995 Jan-Feb       Impact factor: 2.792

3.  Renal safety of tenofovir in HIV-infected children: a prospective, 96-week longitudinal study.

Authors:  A Viganò; G V Zuccotti; L Martelli; V Giacomet; L Cafarelli; S Borgonovo; S Beretta; G Rombolà; S Mora
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

4.  MODIFIED BROMOPHENOL BLUE DYE BINDING METHOD FOR QUANTITATION OF MICROALBUMINURIA IN DIABETES MELLITUS.

Authors:  B L Somani; T K Saha; M M Arora; Y V Sharma
Journal:  Med J Armed Forces India       Date:  2017-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.